Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Med Care. 2011 Apr;49(4):420-3. doi: 10.1097/MLR.0b013e3182028ca3.
Healthcare costs are increased by the adoption of novel technologies before solid evidence on efficacy and risks. Oocyte cryopreservation for preserving fertility raises special ethical challenges. We compared opinions of professionals for assisted reproductive technology (ART), bioethicists, medical students and the general population toward the questions: do you support access to oocyte cryopreservation to preserve fertility for personal reasons and who should bear the costs?
The surveys conducted for this study were carried out in Israel included the following: (1) survey of 21 ART unit directors; (2) interviews with 23 bioethics experts; (3) survey of 196 medical students from 2 universities; (4) random digit-dial population-based survey of the public (N=600).
Nearly 80% of ART and bioethics experts and 56% of students thought that oocyte cryopreservation should be allowed even for personal reasons. While expressing concerns about social consequences, bioethicists emphasized individuals' rights. In contrast, among the public, only 40% supported the use of this technology for personal reasons (ranging from 24% among Ultra-orthodox Jews and Arabs, to 51% among seculars or with academic education). Of note, 15% were undecided (vs. <2% among students, P<0.001). Most experts suggested private financing of the procedure for personal reasons, whereas the public preferred national or private insurance coverage.
Nonexperts present a greater level of ambivalence than experts toward the use of a novel fertility technology for nonmedical reasons. Experts' preferences and interests may facilitate adoption of novel technologies with yet unclear effectiveness and safety, potentially contributing to increased healthcare costs.
在有确凿的疗效和风险证据之前,采用新技术会增加医疗保健成本。卵母细胞冷冻保存以保留生育能力引发了特殊的伦理挑战。我们比较了辅助生殖技术(ART)专业人员、生物伦理学家、医学生和普通公众对以下问题的看法:您是否支持出于个人原因获得卵母细胞冷冻保存以保留生育能力,以及应由谁承担费用?
这项研究进行的调查包括在以色列进行的以下内容:(1)对 21 个 ART 单位主任的调查;(2)对 23 名生物伦理专家的访谈;(3)对来自 2 所大学的 196 名医学生的调查;(4)对公众(N=600)进行随机数字拨号的基于人群的调查。
近 80%的 ART 和生物伦理专家以及 56%的学生认为,即使出于个人原因,也应该允许卵母细胞冷冻保存。生物伦理学家在表达对社会后果的担忧的同时,强调了个人的权利。相比之下,在公众中,只有 40%的人支持出于个人原因使用这项技术(从正统派犹太人和阿拉伯人 24%到世俗派或受过学术教育的人 51%不等)。值得注意的是,有 15%的人犹豫不决(而学生中只有 2%,P<0.001)。大多数专家建议出于个人原因为该程序提供私人融资,而公众则更喜欢国家或私人保险覆盖。
与专家相比,非专家对出于非医疗原因使用新型生育技术表现出更大程度的矛盾。专家的偏好和利益可能会促进采用尚未明确有效性和安全性的新型技术,从而有可能导致医疗保健成本增加。